DxConference Agenda Overview

Boston, Massachusetts  |  March 8-9, 2018

Foley Hoag Seaport West Offices


Day 1: March 8, 2018

7:00-8:15AM

Registration & Check-In

7:30-8:30AM

Breakfast Buffet

8:15-8:30AM

Welcome & Opening Remarks

Mark Spykerman, Senior Vice President, Transformation at AmerisourceBergen

8:30-9:45AM

 

KEYNOTE: State of the Industry

Hannah Murphy, Executive Director of the Coalition for 21st Century Medicine

KEYNOTE: Legal Insights on the Latest Emerging Regulations

Brian Carey, Partner Foley Hoag

9:45AM-10:30AM

MolDx After the NCD

Girish Putcha, MD, Director of Laboratory Services Palmetto MolDx

10:30-10:45AM

Networking Break

10:45 – 11:30AM

 

PLAYING TO WIN IN THE LAB SPACE

Damon Cox, Vice President Health Plans, Counsyl

11:30 – 12:00PM

 

12:00 – 1:00PM

Metagenomics: The Next Technology Innovation in Diagnostic Testing

Jeffrey A. Field, M.S., MBA, Chief Commercial Officer, IDbyDNA

Lunch

1:00 – 1:30PM

Coding Gone Wild: Things You Never Thought You'd See

Lon Castle, eviCore

1:30 – 2:30PM

 

The Evolving Role of Companion Diagnostics in the Precision Medicine Era

Matt Franklin, Senior Vice President Global Marketing, Foundation Medicine

2:30 – 3:00PM     

Networking Break

3:00 – 3:45PM          

The Reality of Prior Authorization: Early results from Anthem and UHC

Walt Williams, Director, Revenue Optimization & Strategy, Quadax

3:45 – 4:15PM       

Decreasing Liability - How to Avoid the Orange Jumpsuit

Colin Zick, Partner Foley Hoag

4:15 – 5:00PM

 

5:00 – 6:30PM

finding a balance: relationship between business & science

DISTINGUISHED PANEL DISCUSSION Moderated By: Lauren Feldman, Director, ADVI Health

Sapna Syngal, M.D., MPH, Dana Farber Cancer Institute

Rachel Anhorn, Pharmd, Director, Payor Policy And Health Outcome, Foundation Medicine

Mikael Marriott Barmore, Director Of Marketing & Commercialization, Myriad

Cocktail Reception Sponsored By Foley Hoag


Day 2: March 9, 2018

7:30-8:30AM

Breakfast Buffet

8:30-8:45AM

Welcome & OPENING REMARKS

Charene Pillai, Senior Director, Lash Group

8:45-9:30AM

KEYNOTE: Latest From the Beltway

John Stone, Vice President, BGR Group

9:30-10:30AM

The Next Gen of Evidence Street

Suzanne Belinson, Executive Director, Office of Clinical Affairs Evidence Street, Blue